Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Pak J Biol Sci ; 13(11): 527-36, 2010 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-21848066

RESUMO

To evaluate neurological changes developing during paediatric Acute Lymphoblastic Leukaemia (ALL) therapy clinically and through electrophysiological Study of Somatosensory Evoked Potentials (SSEPs) changes in different phases of therapy. Thirty five-ALL patients with age range from 3-14 years were included compared to 30 healthy controls. History, neurological examination, complete blood counts, cytological examination of bone marrow aspirate and cerebrospinal fluid with Measurement of Serum Methotrexate (MTX) were done. The SSEPs were performed and patients subjected to another SSEP with measurement of serum MTX level before and 10 days after intra-thecal injection (IMTX). Clinical neurological findings in patients after induction were depressed deep tendon reflexes (43.3%), hypotonia (28.6%), lost pain sensation (28.6%), muscle weakness (17.1%) and movement disorders (17.1%). Percentage of delayed SSEPs after induction were at levels of brachial plexus (28.6%), spinal cord (68.6%), cortical conduction (31.4%), ERB-N13 Inter Peak Latency (IPL) (74.3%) and N13-N20 IPL (17.1%) in the studied patients. Significant prolonged latency of N13 (p = 0.005), N20 (p = 0.04) and IPL of ERB-N 13 (p = 0.005), N13-N20 (p = 0.01), Inter-Side Difference (ISD) of N13 (p = 0.01), ERB-N13 (p = 0.02) and N13-N20 (p = 0.03) after induction compared to values at diagnosis. Significant positive correlation were found between serum MTX after IMTX with N13-N20 IPL (p = 0.01), N20 ISD (p = 0.03) with significant prolongation in N20 latency, N13-N20 IPL and ISD of N20 compared to values before injection. ALL patients have prolonged latency of SSEPs at cervical cord and cortical levels which increased after IMTX due to axonal injury throughout the cord. SSEPs could be an early diagnostic tool for subclinical neuropathy.


Assuntos
Antimetabólitos Antineoplásicos/sangue , Metotrexato/sangue , Síndromes Neurotóxicas/complicações , Síndromes Neurotóxicas/diagnóstico , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicações , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico , Adolescente , Estudos de Casos e Controles , Criança , Pré-Escolar , Simulação por Computador , Egito , Eletrodos , Eletrofisiologia , Potenciais Somatossensoriais Evocados/fisiologia , Feminino , Humanos , Masculino , Risco
2.
Haemophilia ; 6(6): 635-8, 2000 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-11122388

RESUMO

The frequency of factor VIII inhibitor development was evaluated in a hundred severe haemophilia A patients < 18 years of age (mean 10.4 +/- 5.1 years); 25 were previously untreated patients (PUPs), with a mean age of 11.2 +/- 2.9 months. All were followed up for 3 years from December 1996. Immune tolerance (IT) was induced with low-dose factor VIII (FVIII); 25-50 IU kg(-1) every other day for the 10 haemophiliacs who developed persistent inhibitors. The incidence of inhibitors for PUPs was 3/25 (12%; 95% confidence interval [CI], 0. 7-24.7%) and were detected after 4, 15 and 20 exposure days (mean 13 +/- 8.2 days; 95% CI, 3.7-22.2%). Children with maximum inhibitor levels of > 40 Bethesda units (BU) per mL (n=4) received IT therapy as 25 U kg(-1) FVIII in the form of cryoprecipitate every other day for 1-4 months (mean 2.4 +/- 1.6 months; 95% CI, 0.8-3.9%), which was successful in all of them. FVIII (50 U kg(-1)) was given every other day for six patients with maximum inhibitor level > 40 BU mL(-1) for 3-9 months (mean 5.4 +/- 3.2 months; 95% CI, 2.9 -7.9%) with success in 4/6 (66.6%; 95% CI, 28.8-104.3%). Patients who showed a good IT response had an inhibitor level < or = 30 BU mL(-1), were < or = 9 years of age at inhibitor development with few exposure days to FVIII and had an early immune tolerance. In conclusion, inhibitor development in severe haemophilia A children exclusively treated with cryoprecipitate is low. Early low-dose IT induction for high responders may be achieved successfully if inhibitor level is < or = 50 BU mL(-1).


Assuntos
Anticorpos/imunologia , Fator VIII/imunologia , Fator VIII/uso terapêutico , Hemofilia A/tratamento farmacológico , Hemofilia A/imunologia , Adolescente , Anticorpos/sangue , Criança , Pré-Escolar , Fator VIII/isolamento & purificação , Congelamento , Hemofilia A/sangue , Humanos , Tolerância Imunológica , Lactente
3.
J Egypt Soc Parasitol ; 30(3): 929-42, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11198390

RESUMO

The survival rate of B. alexandrina snails maintained in aqueous solutions of the two tested plants (Calendula micrantha and Anagallis arvensis) decreased gradually with time until the 9th week and 10th week where the survival rate was zero in the high concentration of A. arvensis and C. micrantha, respectively, meanwhile, the survival rate of the control was 20%. Also, the two plants caused reduction in hatchability of snails egg masses. Thus, the percent of hatching in A. arvensis (82 ppm) was 46% and in C. micrantha was 72% compared with control (97.29%). Both plants reduced the infection rate of Biomphalaria alexandrina snails with Schistosoma mansoni miracidia to 41.17% and 61.9%, respectively, compared with control (90%). C. micrantha caused much higher reduction in snail infection rate than A. arvensis. The prepatent period was significantly prolonged in snails maintained at higher concentration of both plants. The cercarial output (expressed as mean number/snail) revealed that, A. arevensis caused a significant reduction in cercarial production than control. While, high concentration (120 ppm) of C. micrantha caused a significant elevation in the mean number of cercariae/snail. However, the total number of cercariae produced by all snails in each group showed a reverse relation with the tested concentrations in both plants.


Assuntos
Asteraceae/efeitos dos fármacos , Biomphalaria/efeitos dos fármacos , Difosfatos/farmacologia , Fertilizantes , Magnoliopsida/efeitos dos fármacos , Moluscocidas/farmacologia , Nitratos/farmacologia , Sulfatos/farmacologia , Animais , Asteraceae/metabolismo , Magnoliopsida/metabolismo , Moluscocidas/metabolismo , Esquistossomose/prevenção & controle
4.
Acta Otolaryngol ; 118(3): 409-12, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9655218

RESUMO

The vomeronasal system in adult humans has commonly been regarded as absent or vestigial, but recently it was found to be more common than previously reported. In this study, a search for the frequency of occurrence of the vomeronasal organ (VNO) was performed by examining the nasal septae of 200 adult patients. The frequency of occurrence was found to vary according to the method of examination. By anterior rhinoscopy, large pits and even deep grooves lined by glistening mucosa were visible in 16% of the people examined. Using nasal endoscopes this ratio increased to 76%. After receiving informed, written consent, from 13 patients undergoing endonasal surgery under general anaesthesia, one VNO was dissected out. Specimens were examined histologically and histochemically for succinic dehydrogenase and alkaline phosphatase enzymes. One specimen was processed for transmission electron microscopy. Two morphologically distinct cell types were differentiated. One cell type was previously suggested to have some of the features associated with nerve cells and could have a sensory function. A possible function for the VNO is postulated.


Assuntos
Órgão Vomeronasal/anatomia & histologia , Órgão Vomeronasal/enzimologia , Adulto , Fosfatase Alcalina/análise , Endoscopia , Humanos , Microscopia Eletrônica , Succinato Desidrogenase/análise , Órgão Vomeronasal/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...